167 related articles for article (PubMed ID: 31485922)
1. Impact of the American Tax Payer Relief Act on stereotactic radiosurgery utilization in the United States.
McClelland S; Degnin C; Chen Y; Watson GA; Jaboin JJ
J Neurooncol; 2019 Oct; 145(1):159-165. PubMed ID: 31485922
[TBL] [Abstract][Full Text] [Related]
2. Changing practice patterns of Gamma Knife versus linear accelerator-based stereotactic radiosurgery for brain metastases in the US.
Park HS; Wang EH; Rutter CE; Corso CD; Chiang VL; Yu JB
J Neurosurg; 2016 Apr; 124(4):1018-24. PubMed ID: 26473783
[TBL] [Abstract][Full Text] [Related]
3. The impact of EGFR-TKI use on clinical outcomes of lung adenocarcinoma patients with brain metastases after Gamma Knife radiosurgery: a propensity score-matched analysis based on extended JLGK0901 dataset (JLGK0901-EGFR-TKI).
Yomo S; Serizawa T; Yamamoto M; Higuchi Y; Sato Y; Shuto T; Akabane A; Jokura H; Kawagishi J; Aoyama H
J Neurooncol; 2019 Oct; 145(1):151-157. PubMed ID: 31487030
[TBL] [Abstract][Full Text] [Related]
4. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
[TBL] [Abstract][Full Text] [Related]
5. Predictors of linear accelerator versus Gamma Knife stereotactic radiosurgery use for brain metastases in the United States.
McClelland Iii S; Degnin C; Chen Y; Watson GA; Jaboin JJ
J Radiosurg SBRT; 2020; 6(4):263-267. PubMed ID: 32185085
[TBL] [Abstract][Full Text] [Related]
6. Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery.
Taunk NK; Oh JH; Shukla-Dave A; Beal K; Vachha B; Holodny A; Hatzoglou V
Neuro Oncol; 2018 Mar; 20(4):567-575. PubMed ID: 29016814
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
8. Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.
Halasz LM; Weeks JC; Neville BA; Taback N; Punglia RS
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):e109-16. PubMed ID: 23058058
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic radiosurgery for brain metastases from newly diagnosed small cell lung cancer: practice patterns and outcomes.
Jiang W; Haque W; Verma V; Butler B; Teh BS
Acta Oncol; 2019 Apr; 58(4):491-498. PubMed ID: 30676131
[TBL] [Abstract][Full Text] [Related]
10. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
11. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
12. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
[TBL] [Abstract][Full Text] [Related]
13. Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study.
Ascha MS; Funk K; Sloan AE; Kruchko C; Barnholtz-Sloan JS
Clin Exp Metastasis; 2020 Feb; 37(1):85-93. PubMed ID: 31705229
[TBL] [Abstract][Full Text] [Related]
14. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
15. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
16. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
Bougie E; Masson-Côté L; Mathieu D
World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
[TBL] [Abstract][Full Text] [Related]
17. Radiosurgery alone for 5 or more brain metastases: expert opinion survey.
Knisely JP; Yamamoto M; Gross CP; Castrucci WA; Jokura H; Chiang VL
J Neurosurg; 2010 Dec; 113 Suppl():84-9. PubMed ID: 21121790
[TBL] [Abstract][Full Text] [Related]
18. Lymphopenia predicts response to stereotactic radiosurgery in lung cancer patients with brain metastases.
Li YD; Lamano JB; Kaur G; Lamano JB; Veliceasa D; Biyashev D; Kruser T; Bloch O
J Neurooncol; 2019 Jun; 143(2):337-347. PubMed ID: 30982197
[TBL] [Abstract][Full Text] [Related]
19. Management of brain metastases from large cell neuroendocrine carcinoma of the lung: improved outcomes with radiosurgery.
Wegner RE; Hasan S; Williamson RW; Finley G; Fuhrer R; Colonias A; Karlovits SM
Acta Oncol; 2019 Apr; 58(4):499-504. PubMed ID: 30732516
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive functioning after Gamma Knife and LINAC stereotactic radiosurgery in patients with brain metastases.
Albers EAC; de Ruiter MB; van de Poll-Franse LV; Merckel LG; Compter A; Schagen SB
J Neurooncol; 2022 Dec; 160(3):649-658. PubMed ID: 36454373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
